Treating depression during COVID-19: Considerations for psychological and psychiatric treatment

Presented by Rachel Leonard, PhD, LP, and Christopher Lowden, MD

View slides from this presentation

Review behavioral activation theory and pharmacotherapy for depression, and gain an understanding of the benefits of a combined approach, in part one of this webinar series. Time will also be spent identifying necessary modifications for pharmacotherapy during COVID-19 and adaptations for behavioral activation, which are necessary when treatment is provided via telehealth.

 

Related resources

#
Treating co-occurring generalized anxiety disorder and depression: Expert tips to keep your clients from getting stuck
Learn about the most common dilemmas that arise when treating patients with…
Learn more
#
Rising Above Mood Disorders: Meg’s Story
Meg shares that after years of psychiatric hospitalizations, she turned to…
Learn more
#
Live Q&A: New self-care tips for the new year
Riggs Radio from 103.7 KISS-FM Milwaukee moderates this discussion on…
Learn more

Call 800-767-4411 or go to rogersbh.org to request a free screening.